US2013020227A1PendingUtilityA1
Post-operative cataract kit and method
Est. expiryJul 20, 2031(~5 yrs left)· nominal 20-yr term from priority
Inventors:Edward P. Stack
A61K 9/0048A61J 7/0053A61F 9/0008A61J 1/16A61F 9/02A61J 1/065A61J 7/0409
20
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A kit for use post-operatively by patients who have undergone cataract surgery and are unable to gather the medications and eyewear required for recovery, comprising a container for antibiotic and anti-inflammatory medications, special eyeglasses, an eye shield, and instructions for use of the contained products.
Claims
exact text as granted — not AI-modified1 . A kit for use post-operatively by patients who have undergone cataract surgery comprising, in a reclosable container, an assembly of the medications prescribed by the patient's physician for post-operative use by the patient and protective devices recommended by the patient's physician for improvement of the patient's overall treatment, the protective devices comprising sunglasses and eye shields.
2 . The kit of claim 1 , wherein the post-operative eye medications contained within the kit comprise a topical antibiotic and a topical anti-inflammatory medication.
3 . The kit of claim 2 , wherein the anti-inflammatory medication comprises a topical non-steroidal anti-inflammatory medication.
4 . The kit of claim 1 , wherein the assembly in the kit comprises instruction sheets for the components of the kit.
5 . The kit of claim 4 , wherein the instruction sheets comprise anti-infective and anti-inflammatory administration and dosage information.
6 . The kit of claim 1 , wherein the reclosable container comprises a bag.
7 . The kit of claim 2 , wherein the topical antibiotic pharmaceuticals in the kit comprise an effective amount of a broad spectrum topical antibiotic eye drop.
8 . The kit of claim 7 , wherein the broad spectrum antibiotic is selected from a group consisting of gatifloxacin, moxifloxacin, ciprofloxacin, ofloxacin, levofloxacin, and besifloxacin.
9 . The kit of claim 2 , wherein the steroidal anti-inflammatory medication is selected from a group consisting of prednisolone acetate, difluprednate, loteprednol etabonate, or fluorometholone.
10 . The kit of claim 2 , wherein the topical antibiotic is chosen from the group comprising gatifloxacin, moxifloxacin, ciprofloxacin, ofloxacin, levofloxacin, and besifloxacin.
11 . A kit for use post-operatively by patients of cataract surgery, the kit being supported in a manually openable and closable container, and comprising a topical antibiotic, a topical non-steroidal anti-inflammatory medication, a topical steroidal anti-inflammatory medication, and an eyewear apparatus.
12 . The kit of claim 11 , wherein the topical antibiotic is a broad spectrum antibiotic.
13 . The kit of claim 12 , wherein the broad spectrum antibiotic is selected from a group consisting of gatifloxacin, moxifloxacin, ciprofloxacin, ofloxacin, levofloxacin, and besifloxacin.
14 . The kit of claim 11 , wherein the non-steroidal anti-inflammatory medication is selected from a group consisting of ketorolac tromethamine, bromfenac, diclofenac, or nepafenac.
15 . The kit of claim 11 , wherein the steroidal anti-inflammatory medication is selected from the group consisting of prednisolone acetate, difluprednate, loteprednol etabonate, or fluorometholone.
16 . A kit for use post-operatively by patients of cataract surgery to improve their recovery, avoid post-operative complications, and increase patient comfort during the healing process, comprising antibiotic medications, anti-inflammatory medications, eyewear for shielding the patient's eye from light in both the visible and nonvisible spectrums, and printed instructions for the use of the medications and the eyewear, all disposed in a reclosable container.
17 . The kit of claim 16 , wherein the eyewear contained within the kit comprises a pair of sunglasses which are wearable over prescription eyeglasses.
18 . The kit of claim 16 , wherein the eyewear comprises an eye shield.Join the waitlist — get patent alerts
Track US2013020227A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.